Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Fig. 1

Quantitative Proteomic Analysis. a Schematic overview of the strategy used for the iTRAQ analysis. b Venn diagram showing the distribution of the 1979 identified proteins in each subcellular fraction. c Heat map and patient clustering according to the protein expression profiles. Each row represents one protein; columns represent the T lymphocyte samples of patients with (n = 2) and without (n = 2) grade ≥ 2 bf + after irradiation (8 Gy) or not (0 Gy). In a: eliminate population, change into T lymphocytes

Back to article page